Mayo Clinic, along with other members of the Geroscience Network, has published six manuscripts that map strategies for taking new drugs that target processes underlying aging into clinical trials.
Researchers believe that these agents hold promise for treating multiple age-related diseases and disabilities. The articles appear in The Journals of Gerontology: Series A — Biological Sciences and Medical Sciences.
